Cargando…

Prion-like spreading of pathological α-synuclein in brain

α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of neurodegenerative α-synucleinopathies. However, the molecular mechanisms underlying α-synuclein accumulation and spread are unclear. Here we show that intracerebral injections of sarkosyl-inso...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda-Suzukake, Masami, Nonaka, Takashi, Hosokawa, Masato, Oikawa, Takayuki, Arai, Tetsuaki, Akiyama, Haruhiko, Mann, David M. A., Hasegawa, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613715/
https://www.ncbi.nlm.nih.gov/pubmed/23466394
http://dx.doi.org/10.1093/brain/awt037
_version_ 1782264769375371264
author Masuda-Suzukake, Masami
Nonaka, Takashi
Hosokawa, Masato
Oikawa, Takayuki
Arai, Tetsuaki
Akiyama, Haruhiko
Mann, David M. A.
Hasegawa, Masato
author_facet Masuda-Suzukake, Masami
Nonaka, Takashi
Hosokawa, Masato
Oikawa, Takayuki
Arai, Tetsuaki
Akiyama, Haruhiko
Mann, David M. A.
Hasegawa, Masato
author_sort Masuda-Suzukake, Masami
collection PubMed
description α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of neurodegenerative α-synucleinopathies. However, the molecular mechanisms underlying α-synuclein accumulation and spread are unclear. Here we show that intracerebral injections of sarkosyl-insoluble α-synuclein from brains of patients with dementia with Lewy bodies induced hyperphosphorylated α-synuclein pathology in wild-type mice. Furthermore, injection of fibrils of recombinant human and mouse α-synuclein efficiently induced similar α-synuclein pathologies in wild-type mice. C57BL/6J mice injected with α-synuclein fibrils developed abundant Lewy body/Lewy neurite-like pathology, whereas mice injected with soluble α-synuclein did not. Immunoblot analysis demonstrated that endogenous mouse α-synuclein started to accumulate 3 months after inoculation, while injected human α-synuclein fibrils disappeared in about a week. These results indicate that α-synuclein fibrils have prion-like properties and inoculation into wild-type brain induces α-synuclein pathology in vivo. This is a new mouse model of sporadic α-synucleinopathy and should be useful for elucidating progression mechanisms and evaluating disease-modifying therapy.
format Online
Article
Text
id pubmed-3613715
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-36137152013-04-03 Prion-like spreading of pathological α-synuclein in brain Masuda-Suzukake, Masami Nonaka, Takashi Hosokawa, Masato Oikawa, Takayuki Arai, Tetsuaki Akiyama, Haruhiko Mann, David M. A. Hasegawa, Masato Brain Original Articles α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of neurodegenerative α-synucleinopathies. However, the molecular mechanisms underlying α-synuclein accumulation and spread are unclear. Here we show that intracerebral injections of sarkosyl-insoluble α-synuclein from brains of patients with dementia with Lewy bodies induced hyperphosphorylated α-synuclein pathology in wild-type mice. Furthermore, injection of fibrils of recombinant human and mouse α-synuclein efficiently induced similar α-synuclein pathologies in wild-type mice. C57BL/6J mice injected with α-synuclein fibrils developed abundant Lewy body/Lewy neurite-like pathology, whereas mice injected with soluble α-synuclein did not. Immunoblot analysis demonstrated that endogenous mouse α-synuclein started to accumulate 3 months after inoculation, while injected human α-synuclein fibrils disappeared in about a week. These results indicate that α-synuclein fibrils have prion-like properties and inoculation into wild-type brain induces α-synuclein pathology in vivo. This is a new mouse model of sporadic α-synucleinopathy and should be useful for elucidating progression mechanisms and evaluating disease-modifying therapy. Oxford University Press 2013-04 2013-03-06 /pmc/articles/PMC3613715/ /pubmed/23466394 http://dx.doi.org/10.1093/brain/awt037 Text en © The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Masuda-Suzukake, Masami
Nonaka, Takashi
Hosokawa, Masato
Oikawa, Takayuki
Arai, Tetsuaki
Akiyama, Haruhiko
Mann, David M. A.
Hasegawa, Masato
Prion-like spreading of pathological α-synuclein in brain
title Prion-like spreading of pathological α-synuclein in brain
title_full Prion-like spreading of pathological α-synuclein in brain
title_fullStr Prion-like spreading of pathological α-synuclein in brain
title_full_unstemmed Prion-like spreading of pathological α-synuclein in brain
title_short Prion-like spreading of pathological α-synuclein in brain
title_sort prion-like spreading of pathological α-synuclein in brain
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613715/
https://www.ncbi.nlm.nih.gov/pubmed/23466394
http://dx.doi.org/10.1093/brain/awt037
work_keys_str_mv AT masudasuzukakemasami prionlikespreadingofpathologicalasynucleininbrain
AT nonakatakashi prionlikespreadingofpathologicalasynucleininbrain
AT hosokawamasato prionlikespreadingofpathologicalasynucleininbrain
AT oikawatakayuki prionlikespreadingofpathologicalasynucleininbrain
AT araitetsuaki prionlikespreadingofpathologicalasynucleininbrain
AT akiyamaharuhiko prionlikespreadingofpathologicalasynucleininbrain
AT manndavidma prionlikespreadingofpathologicalasynucleininbrain
AT hasegawamasato prionlikespreadingofpathologicalasynucleininbrain